Composition for antigen detection and preparation method
A technology of antigen detection and composition, which is applied in the field of immune detection and can solve problems such as abnormal detection values
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0066] 2. Preparation of biotinylated anti-reagent
[0067] A: Preparation of biotinylation reagent
[0068] In 100mM carbonate solution, cTnI antibody 1 was desalted and concentrated to a final concentration of 2mg / ml; biotin was dissolved in DMSO, and biotin was added to the first cardiac troponin I antibody at a ratio of 10:1 at 37°C Coupling for 2 hours, using a desalting column to remove uncoupled biotin to obtain biotin resistance reagent;
[0069] B: Dilute biotinylated anti-reagent
[0070] Add anti-reagent diluent with the following components to the biotin anti-reagent: 50mM This-HCl buffer, pH=7.4; 0.9% NaCl, 0.5% BSA, 0.09% Proclin-300, 0.1% Tween-20, 1% glycerol, Make the final concentration 1 μg / mL.
[0071] 3. Preparation of magnetic particle composites
[0072] The carboxyl magnetic beads were activated with EDC and washed four times; the antibody was activated with TCEP, concentrated in an ultrafiltration tube and then replaced with PBS buffer; the carboxy...
Embodiment 1
[0084] The impact of the first activator of embodiment 1 on detection result
[0085] Reagent components: 3 mg / mL alkaline phosphatase, 0.66 mg / mL streptavidin, 30 mg / mL first activator, 6.6 mg / mL SDPD.
[0086] The first activator in reagent component 1 is SM (PEG) 4 ;
[0087] The first activator in reagent component 2 is SM (PEG) 8 ;
[0088] The first activator in reagent component 3 is SM (PEG) 12 ;
[0089] The first activator in reagent component 4 is SM (PEG) 24 ;
[0090] The first activator in reagent component 5 is SMCC;
[0091] No first activator was added to reagent component 6.
[0092] The specific operation in this example: the coupling ratio of streptavidin to alkaline phosphatase is 1:4.5, and the ratio of the first activator to the conjugate is 10:1.
[0093] Mix 3mg / mL of alkaline phosphatase with 30mg / mL of the first activator to activate alkaline phosphatase, mix 0.66mg / mL of streptavidin with 6.6mg / mL of SDPD to activate streptavidin , (the fi...
Embodiment 2
[0112] The influence of the second activator of embodiment 2 on detection result
[0113] Reagent components: 3mg / mL alkaline phosphatase, 0.66mg / mL streptavidin, 30mg / mL SM (PEG) 12 , 6.6 mg / mL of the second activating reagent.
[0114] The second activator in reagent component 7 is DTT;
[0115] The second activator in reagent component 8 is TCEP;
[0116] The second activator in reagent component 9 is 2-IT;
[0117] No second activator was added to reagent component 10.
[0118] In this embodiment, the specific operation is to mix 3mg / mL of alkaline phosphatase with 30mg / mL of SM(PEG)12 to activate alkaline phosphatase, and 0.66mg / mL of streptavidin and 6.6mg / mL of The two activators are mixed to activate the streptavidin, (the second activator is not added in the reagent component 10, the streptavidin is directly added after the alkaline phosphatase is activated) and then the activated streptavidin is Mix with activated alkaline phosphatase to prepare alkaline phosphata...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com